saperconazole has been researched along with Dermatomycoses in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Degreef, H | 1 |
| Franco, L; Gomez, I; Restrepo, A | 1 |
| de Beule, D; Dokekias, A; Fillet, G; Hermanns, G; Pierard, GE; Pierard-Franchimont, C; Rurangirwa, A | 1 |
1 review(s) available for saperconazole and Dermatomycoses
| Article | Year |
|---|---|
[New antifungal agents in the treatment of superficial dermatomycoses].
Topics: Administration, Topical; Antifungal Agents; Azoles; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Tolnaftate | 1993 |
2 other study(ies) available for saperconazole and Dermatomycoses
| Article | Year |
|---|---|
Saperconazole in the treatment of systemic and subcutaneous mycoses.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Azoles; Capsules; Child; Chromoblastomycosis; Dermatomycoses; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paracoccidioidomycosis; Remission Induction; Sporotrichosis; Time Factors | 1992 |
[Trichosporon beigelii infection in immunodeficient patients].
Topics: Adult; Antifungal Agents; Azoles; Dermatomycoses; Humans; Immunologic Deficiency Syndromes; Ketoconazole; Male; Middle Aged; Opportunistic Infections; Trichosporon | 1990 |